ReviewFrontiers in endocrinology2022

Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries.

M Zulf Mughal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.